Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
884,72 B | 23,56% | 6/6 | 35,41% | 7,57% | 26,22% | UP |
|
Johnson & Johnson NYSE:JNJ |
579,34 B | 5,27% | 5/6 | 6,84% | -32,27% | -0,17% | UP |
|
Merck NYSE:MRK |
286,28 B | 7,67% | 6/6 | -21,45% | -4,86% | 12,27% | UP |
|
Pfizer NYSE:PFE |
153,81 B | 7,82% | 4/6 | -5,32% | 22,12% | -0,18% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
122,78 B | 1,77% | 5/6 | -0,27% | -3,61% | 6,15% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
116,02 B | 13,44% | 6/6 | 6,44% | -6,33% | 19,99% | UP |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
77,97 B | 9,26% | 5/6 | 5,37% | 2,90% | 15,16% | UP |
|
Zoetis NYSE:ZTS |
51,26 B | 9,80% | 6/6 | 7,26% | 44,13% | 19,41% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
20,96 B | 15,13% | 4/6 | 4,00% | -21,37% | 22,87% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
9,93 B | 0,00% | 2/4 | 0,00% | 0,00% | 47,63% | UP |
|
Cytokinetics NasdaqGS:CYTK |
7,44 B | -1,08% | 1/6 | -3,16% | -30,56% | 48,98% | UP |
|
Balchem NasdaqGS:BCPC |
5,61 B | 8,75% | 6/6 | 8,46% | -0,87% | 15,53% | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
4,02 B | 17,81% | 5/6 | 33,16% | -115,82% | 11,69% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
4,32 B | 63,45% | 3/5 | 31,67% | 93,86% | 57,16% | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
4,03 B | 7,83% | 5/6 | 0,76% | -58,49% | 18,38% | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
3,60 B | 10,36% | 6/6 | -5,14% | 0,96% | 77,15% | DOWN |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
3,10 B | 2,48% | 3/6 | 6,85% | -33,57% | 20,66% | UP |
|
Neogen NasdaqGS:NEOG |
2,11 B | -4,36% | 2/6 | 0,45% | 43,80% | 23,71% | UP |
|
Endo OTCPK:NDOI |
1,80 B | 3,65% | 0/5 | 61,08% | 23,81% | -100,00% | DOWN |
